Researchers investigate the neural patterns of patients with PTSD while listening to narratives that depicted their own memories.
Study reveals significant discrepancies in the labeled and actual cannabidiol content in various commercial products, highlighting a major quality control issue.
Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia Scientific”, or the “Company”), a medical research company with clinics providing innovative ketamine and psilocybin treatments
This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development company, is pleased to announce that
The study published in PNAS reveals that emotions create identifiable maps of bodily sensations, consistent across different cultures and races. Using a novel method named
The “CNS Therapeutics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global CNS Therapeutics Market to Reach $199 Billion by 2030 The global market for
Q4 Fiscal 2023 Highlights Q4 2023 revenues grew 46.8% year-over-year to $6.1 million Q4 2023 revenues grew 1.7% from the previous quarter Gross profit of $1.8 million,
Incannex Healthcare Inc. (NASDAQ: IXHL) is pleased to announce that its previously announced transaction to redomicile Incannex Healthcare from Australia to the United States has
The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” and “intentionally” misrepresenting the effectiveness of its Covid-19 vaccine and attempting to censor